Research has shown that increased levels of cathepsin L are correlated with decreased heart function in dilated cardiomyopathy (Mehra et al., 2017), increased inflammation in rheumatoid arthritis (Weitoft et al., 2015), and increased malignancy of certain cancers (Olson and Joyce, 2015). This evidence concerns the gene CTSL and cancer.